-
Product Insights
Mycobacterium avium Infections - Drugs In Development, 2024
Empower your strategies with our Mycobacterium avium Infections – Drugs In Development, 2024 report and make more profitable business decisions. Mycobacterium avium Infections is the most common cause of nontuberculosis mycobacterial species infections in humans, and the respiratory system is the most common site of infection. It consists of multiple nontuberculosis mycobacterial species (NTM). It is considered an opportunistic infection most observed in immunocompromised ones. It is caused by a group of bacteria most common species is M. avium and its...
-
Product Insights
Progressive Multifocal Leukoencephalopathy - Drugs In Development, 2024
Empower your strategies with our Progressive Multifocal Leukoencephalopathy – Drugs In Development, 2024 report and make more profitable business decisions. Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the brain caused by lytic infection of oligodendrocytes by polyomavirus, also known as JC (John Cunningham) virus. Symptoms include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. Risk factors include the presence of pathogenic JC virus and an altered or weakened immune system, and genetic or environmental factors. The Progressive...
-
Product Insights
Resistant Pseudomonas aeruginosa Infections - Drugs In Development, 2024
Empower your strategies with our Resistant Pseudomonas aeruginosa Infections – Drugs In Development, 2024 report and make more profitable business decisions. Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It has an ability to rapidly develop resistance to multiple classes of antibiotics. It is the most common pathogen isolated from patients who have been hospitalized for more than one week. Signs and symptoms include pneumonia, fever, fatigue, itchy rash, bleeding ulcers, and...
-
Product Insights
Rubella (German Measles) - Drugs In Development, 2024
Empower your strategies with our Rubella (German Measles) – Drugs In Development, 2024 report and make more profitable business decisions. Rubella, also known as German measles, is an acute, contagious viral infection. The rubella virus is transmitted by airborne droplets when infected people sneeze or cough. Symptoms include fever, headache, stuffy or runny nose, red and inflamed eyes, aching joints, and enlarged, tender lymph nodes at the base of the skull, the back of the neck, and behind the ears. The...
-
Product Insights
Rubivirus Infections - Drugs In Development, 2024
Empower your strategies with our Rubivirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Rubi virus Infections causes rubella and is placed in the Rubi virus genus of togaviridae family. It is a single stranded RNA virus causing infections most predominantly in children and is also known as German measles. Mode of transmission is through droplets contacts and spreads to other organs. It can also transmit from mother to fetus through placenta. In most cases it...
-
Product Insights
African Trypanosomiasis - Drugs In Development, 2024
Empower your strategies with our African Trypanosomiasis – Drugs In Development, 2024 report and make more profitable business decisions. African trypanosomiasis (also known as African sleeping sickness) is a parasitic infection caused by a species of parasite, Trypanosoma brucei, which is transmitted to humans through the bite of the tsetse fly. Symptoms include anxiety, drowsiness during the day, fever, headache, insomnia at night, mood changes, sleepiness (may be uncontrollable), sweating, swollen lymph nodes all over the body, weakness, and a swollen,...
-
Product Insights
Bacterial Sepsis - Drugs In Development, 2024
Empower your strategies with our Bacterial Sepsis – Drugs In Development, 2024 report and make more profitable business decisions. Infection caused by bacteria known as bacterial sepsis. Sepsis is an emergency condition when existing infections in the body are triggered or body’s extreme response to an infection. Sepsis can result in multi organ damage and septic shock. It is also referred to as blood poisoning and septicemia. Flu, chest pain, paleness or bluish grey coloration of skin, rashes, SOB, fever, change...
-
Product Insights
Cryptosporidiosis - Drugs In Development, 2024
Empower your strategies with our Cryptosporidiosis – Drugs In Development, 2024 report and make more profitable business decisions. Cryptosporidiosis is an intestinal illness caused by a microscopic parasite called Cryptosporidium. Symptoms include watery diarrhea, dehydration, and lack of appetite, weight loss, fever, nausea, and vomiting. Risk factors include drinking contaminated water, animal handling, and being the parent of and infected child. The Cryptosporidiosis drugs in development market research report provide comprehensive information on the therapeutics under development for Cryptosporidiosis, complete with...
-
Product Insights
Hepatitis A - Drugs In Development, 2024
Empower your strategies with our Hepatitis A – Drugs In Development, 2024 report and make more profitable business decisions. Hepatitis A is inflammation of the liver caused bythe hepatitis A virus. Symptoms include fatigue, nausea and vomiting, inflammation of the liver, loss of appetite, dark urine, muscle pain, and yellowing of the skin and eyes (jaundice). Risk factors include weakened immune system and use of injected or non-injected illicit drugs. Treatment includes antiemetics and pain relievers. The Hepatitis A drugs in...
-
Product Insights
Hepatovirus Infections - Drugs In Development, 2024
Empower your strategies with our Hepatovirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Virus that affecting the functionality of liver (hepatic) known as hepatovirus resulting in hepatitis. These are classified into five different types of hepatitis A, hepatitis B, Hepatitis D, Hepatitis C and hepatitis E. Of all these hepatitis A falls under the genus hepatovirus and it is the small, unenveloped RNA virus and is the only species that affects humans. HAV that belongs...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.